Dr. Brito is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 1st Street SW
Rochester, MN 55905
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Endocrinology, Diabetes, and Metabolism, 2011 - 2014
University of Miami/Jackson Health SystemResidency, Internal Medicine, 2008 - 2011
Universidad Central del Ecuador School of MedicineClass of 2005
Certifications & Licensure
MN State Medical License 2011 - 2025
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Clinical Trials
- Impact of Papillary Microcarcinoma Terminology on Patients Treatment Preferences: a Cross Sectional Survey Start of enrollment: 2016 Mar 01
Publications & Presentations
PubMed
- Developing a framework for understanding diagnostic reconciliation based on evidence review, stakeholder engagement, and practice evaluation.Sandra Algarin Perneth, Gilberto Perez Rodriguez Garcia, Juan P Brito, Tejal Gandhi, Carma L Bylund
Diagnosis. 2025-02-01 - GLP-1RA Use and Thyroid Cancer Risk.Juan P Brito, Jeph Herrin, Kavya Sindhu Swarna, Naykky M Singh Ospina, Victor M Montori
JAMA Otolaryngology-- Head & Neck Surgery. 2025-01-23 - Trends in Osteoporosis Drug Therapy Receipt Among Commercial and Medicare Advantage Enrollees in the United States, 2011-2022.Alexander O Everhart, Juan P Brito, Bart L Clarke, Jeph Herrin, Pinar Karaca-Mandic
The Journal of Clinical Endocrinology and Metabolism. 2025-01-15
Journal Articles
- Comparative Effectiveness of Generic vs Brand-Name Levothyroxine in Achieving Normal Thyrotropin LevelsJuan P Brito, Robert C Smallridge, Victor Bernet, Kasia J Lipska, JAMA Network Open
- Assessment of Shared Decision-Making for Stroke Prevention in Patients with Atrial FibrillationHaeshik Gorr, Takeki Suzuki, Erik Hess, Juan P Brito, Peter A Noseworthy, Victor M Montori, JAMA Internal Medicine
- Patients’ Experiences of Diagnosis and Management of Papillary Thyroid Microcarcinoma: A Qualitative StudyJuan Brito, MD, BioMed Central
Press Mentions
GLP-1 RAs Tied to Higher Thyroid Cancer Risk in First Year of TreatmentJanuary 31st, 2025- HMN 2025: How Glucagon-like Peptide-1 Receptor Agonists Tied to Greater Thyroid Cancer Threat in First 12 Months of TherapyJanuary 31st, 2025
- Glucagon-like Peptide-1 Receptor Agonists Tied to Higher Thyroid Cancer Risk in First Year of TreatmentJanuary 30th, 2025
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
